Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities:
Net income (loss)	$ 58,149	$ 75,726
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation expense, intangible asset and other amortization	32,153	29,766
Stock-based compensation	16,412	16,384
Amortization of deferred commissions	1,544	2,413
Payments of deferred commissions	(1,475)	(1,522)
Equity in earnings of equity method investments	(855)	(2,001)
(Gain) loss on extinguishment of debt	(705)	0
Distributions from equity method investments	921	828
Sales (purchases) of investments, net	15,586	8,784
Deferred taxes, net	7,020	3,392
Changes in operating assets and liabilities:
Accounts receivable, net and other assets	(7,989)	(3,057)
Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities	(22,931)	(24,211)
Operating activities of consolidated investment products ("CIP"):
Net cash provided by (used in) operating activities	(380,267)	(103,015)
Cash Flows from Investing Activities:
Capital expenditures and other asset purchases	(789)	(6,961)
Sale of available-for-sale securities	0	2,023
Net cash provided by (used in) investing activities	8,935	13,470
Cash Flows from Financing Activities:
Payment of long term debt	(61,573)	(39,839)
Common stock dividends paid	(16,460)	(12,244)
Preferred stock dividends paid	(2,084)	(6,253)
Repurchases of common shares	(25,000)	(30,000)
Taxes paid related to net share settlement of restricted stock units	(5,530)	(5,953)
Net subscriptions received from (redemptions/distributions paid to) noncontrolling interests	(5,935)	7,630
Net cash provided by (used in) financing activities	305,840	113,921
Net increase (decrease) in cash, cash equivalents and restricted cash	(65,492)	24,376
Cash, cash equivalents and restricted cash, beginning of period	321,939	254,656
Cash, cash equivalents and restricted cash, end of period	256,447	279,032
Non-Cash Investing Activities:
Change in accrual for capital expenditures	8	(1,784)
Non-Cash Financing Activities:
Increase (decrease) to noncontrolling interests due to consolidation (deconsolidation) of CIP, net	17,137	22,046
Common stock dividends payable	6,288	4,608
Preferred stock dividends payable	0	2,085
Conversion of preferred stock to common stock	115,000	0
Reconciliation of cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at end of period	321,939	279,032
Consolidated entity excluding consolidated investment products
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Realized and unrealized (gains) losses on investments, net	(2,069)	(4,636)
Consolidated Investment Products
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Realized and unrealized (gains) losses on investments, net	6,739	(3,063)
Operating activities of consolidated investment products ("CIP"):
Purchases of investments by CIP	(1,114,801)	(805,599)
Sales of investments by CIP	624,675	588,678
Net proceeds (purchases) of short term investments by CIP	1,434	2,294
(Purchases) sales of securities sold short by CIP, net	267	1,241
Change in other assets of CIP	(2,039)	(184)
Change in liabilities of CIP	(3,472)	7,247
Amortization of discount on notes payable of CIP	11,169	4,505
Cash Flows from Investing Activities:
Change in cash and cash equivalents of CIP due to consolidation (deconsolidation), net	9,724	18,408
Cash Flows from Financing Activities:
Payments on borrowings by CIP	(358,725)	(195,697)
Borrowings by CIP	$ 781,147	$ 396,277